Cardiac Contractility Modulation for Heart Failure: A Meta‐Analysis of Randomized Controlled Trials
- 26 June 2012
- journal article
- research article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (9) , 1111-1118
Abstract
Background: Cardiac contractility modulation (CCM) emerges as a promising device treatment for heart failure (HF). This meta‐analysis aimed to systematically review the latest available randomized evidence on the effectiveness and safety of CCM in HF. Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE were searched in November 2011 to identify eligible randomized controlled trials comparing CCM with sham treatment or usual care. Primary outcomes of interest were all‐cause mortality, all‐cause hospitalizations, and adverse effects. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated for dichotomous data using a random‐effects model. Results: Three studies enrolling 641 participants were included. Pooled analysis showed that, compared to control, CCM did not significantly improve all‐cause mortality (n = 629, RR 1.19, 95% CI 0.50–2.86, P = 0.69), nor was there a favorable effect in all‐cause hospitalizations. No increase in adverse effects with CCM was observed. Conclusions: Meta‐analysis of data from small randomized trials suggests that CCM, although with no clear benefits in improving clinical outcomes, is not associated with worsening prognosis. Large, well‐designed trials are needed to confirm its role in HF patients for whom cardiac resynchronization therapy is contraindicated or unsuccessful. (PACE 2012; 35:1111–1118)Keywords
This publication has 36 references indexed in Scilit:
- What are the costs of heart failure?EP Europace, 2011
- Could exercise unveil the mystery of non-response to cardiac resynchronization therapy?EP Europace, 2011
- Cardiac resynchronisation therapy for heart failure with narrow or normal QRSHeart, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failureAmerican Heart Journal, 2011
- Augmentation of Left Ventricular Contractility by Cardiac Sympathetic Neural StimulationCirculation, 2010
- Cardiac contractility modulation in non-responders to cardiac resynchronization therapyEP Europace, 2008
- Electrical Signals Applied During the Absolute Refractory PeriodJACC, 2005
- Mechanical Device–Based Methods of Managing and Treating Heart FailureCirculation, 2005
- Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005